Submitting OIG:
Report Description:
For a covered outpatient drug to be eligible for Federal reimbursement under the Medicaid program's drug rebate requirements, manufacturers must pay rebates to the States for the drugs. However, a prior OIG audit found that States did not always invoice and collect all rebates due for drugs administered by physicians.
Date Issued:
Wednesday, February 19, 2020
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-02-18-01011
Component, if applicable:
Centers for Medicare & Medicaid Services
External entity, if applicable:
State of New York
Location(s):
NY
United StatesType of Report:
Audit
Questioned Costs:
$6,399,243
Funds for Better Use:
$0
Number of Recommendations:
5
View Document:
Attachment | Size |
---|---|
21801011.pdf | 1.27 MB |
Additional Details Link: